Logitech Announces Q4 and Full Fiscal Year 2026 Results May 5, 2026 Strong FY 2026 Demonstrates Strategy and Operating Principles Are Delivering
IGI Reports First Quarter of 2026 Unaudited Financial Results May 5, 2026 International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today reported financial results for the first quarter of 2026. Highlights for the first quarter of 2026 include: (in millions of U.S. Dollars, except percentages and per share information) Quarter Ended March 31, 2026 2025 Gross written premiums $197.2 $206.5 Net premiums [...]
KBRA Assigns Preliminary Ratings to GS Mortgage-Backed Securities Trust 2026-IRRP1 DAC May 5, 2026 KBRA Europe (KBRA) assigns preliminary ratings to six classes of notes to be issued by GS Mortgage-Backed Securities Trust 2026-IRRP1 DAC, a static RMBS securitisation collateralised by predominantly reperforming mortgage loans. As of 31 March 2026, the underlying collateral is a €459.7 million portfolio consisting of €451.2 million seasoned first lien performing and reperforming mortgages [...]
True Establishes Global Longevity Practice to Place Leaders Redefining Health, Aging, and Human Potential May 5, 2026 Executive Search Expertise Across Life Sciences, Healthcare, and Consumer Join Forces to Help Companies Translate Science into Scalable Healthspan Solutions
De’ Longhi and La Marzocco Redefine the Coffee Experience at Milan Design Week 2026 May 5, 2026 In the heart of Brera, Milan’s most iconic neighbourhood, the Group celebrated coffee, design, and innovation with two immersive spaces: CASA La Marzocco and The Smallest Coffee Shop at Home with De’ Longhi
Cloudflare Named a Leader in Edge Development Platforms Report by Independent Research Firm May 5, 2026 Cloudflare receives the highest possible scores in 12 criteria, including Vision, Innovation, Roadmap, and AI Application Development
Alkermes plc Reports First Quarter 2026 Financial Results May 5, 2026 Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter ended March 31, 2026 and financial expectations for full year 2026. To view the detailed first quarter 2026 earnings press release and presentation, please visit the company’s investor relations website at https://investor.alkermes.com. Alkermes will host a conference call and webcast presentation at 8:00 a.m. [...]
RS2 Expands Latin America Footprint Through Major Long-Term Processing Agreement May 5, 2026 New partnership extends RS2’s acquiring and issuing capabilities across eight additional markets, reinforcing BankWORKS® as a platform for regional payments growth
D-Wave Announces Qubits Europe 2026 Quantum Computing User Conference May 5, 2026 Event will bring together leading quantum innovators, customers and experts to explore how quantum computing is delivering real-world impact Company to share latest technology roadmap and progress with annealing and gate-model quantum computing, hybrid-quantum software and quantum artificial intelligence (AI)
Jeito Capital Bolsters Its Leadership Team With the Appointment of Elaine Caughey, MBA, as Partner, Business Development and Investor Relations, and Sarah Shackelton, MPA, as Partner, Talent May 5, 2026 Highly experienced partners bringing 25+ years of leadership across top-tier life-sciences investment fund, pharma and Biopharma companies, driving accelerated portfolio development With leadership experience at Blackstone Life Sciences (Deputy Chief Operating Officer), Biogen, (NASDAQ: BIIB), and public and private Biopharma companies (including Kymera Therapeutics (NASDAQ: KYMR) and Cygnal Therapeutics), Elaine Caughey will support portfolio companies in strengthening operational execution, defining robust market access pathways, and enhancing their strategic value through business development support, including partnerships and acquisition transactions. She will also draw on her knowledge of the investment ecosystem to strengthen relationships with investors for both Jeito funds and its portfolio companies Sarah brings deep strategic expertise from senior roles at leading Biopharma investment firms - including as Partner, Marketing and Talent at Abingworth and as Chief Talent Officer at Oxford Science Enterprises - and top executive search firms including Coulter Partners and Spencer Stuart. She will focus on building exceptional senior leadership teams and boards across Jeito and its portfolio, attracting the high calibre talent that powers company acceleration and scale
